Joseph Errico
Director of Finance/CFO presso ONDINE BIOMEDICAL INC.
Patrimonio netto: 922 632 $ in data 29/02/2024
Profilo
Joseph P.
Errico founded 5 companies, notably: electroCore, Inc., SpineCore, Inc. and K2 Medical Systems Ltd.
Currently, Mr. Errico holds the position of Chief Financial Officer of Ondine Biomedical, Inc. Mr. Errico is also Managing Director at Core Ventures II LLC.
Joseph P.
Errico previously held the position of Director at electroCore, Inc. (he founded the company in 2005), Chief Executive Officer at SpineCore, Inc. (he founded the company in 2001) and General Manager-Motion Preservation Unit at Stryker Corp.
Mr. Errico received an undergraduate degree from Massachusetts Institute of Technology, an undergraduate degree and a graduate degree from Duke University and a graduate degree from Duke University School of Law.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
ELECTROCORE, INC.
2.22% | 15/05/2023 | 133 136 ( 2.22% ) | 922 632 $ | 29/02/2024 |
Posizioni attive di Joseph Errico
Società | Posizione | Inizio |
---|---|---|
ONDINE BIOMEDICAL INC. | Director of Finance/CFO | 16/01/2024 |
Core Ventures II LLC
Core Ventures II LLC Investment ManagersFinance Core Ventures II LLC operates as a venture capital firm. The company is headquartered in Short Hills, NJ. | Corporate Officer/Principal | - |
Precedenti posizioni note di Joseph Errico
Società | Posizione | Fine |
---|---|---|
ELECTROCORE, INC. | Chief Executive Officer | 01/07/2016 |
STRYKER CORPORATION | Corporate Officer/Principal | 01/12/2007 |
SpineCore, Inc.
SpineCore, Inc. Industrial MachineryProducer Manufacturing SpineCore, Inc. was a privately-owned developer of artificial lumbar and cervical discs located at Summit, NJ. SpineCore was founded in 2001 by Thomas Errico, MD and J.P. Errico | Chief Executive Officer | 01/08/2004 |
Morphogenesis, Inc.
Morphogenesis, Inc. BiotechnologyHealth Technology Morphogenesis, Inc. develops targeted immunotherapies research. It focuses on the development of cell and gene therapies for the treatment of cancer. The company was founded by Patricia Lawman and Michael Lawman in 1990 and is headquartered in Tampa, FL. | Director/Board Member | - |
Ad4 Pharma | Founder | - |
Formazione di Joseph Errico
Duke University | Graduate Degree |
Massachusetts Institute of Technology | Undergraduate Degree |
Duke University School of Law | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
STRYKER CORPORATION | Health Technology |
ONDINE BIOMEDICAL INC. | Health Technology |
ELECTROCORE, INC. | Health Technology |
Aziende private | 6 |
---|---|
Morphogenesis, Inc.
Morphogenesis, Inc. BiotechnologyHealth Technology Morphogenesis, Inc. develops targeted immunotherapies research. It focuses on the development of cell and gene therapies for the treatment of cancer. The company was founded by Patricia Lawman and Michael Lawman in 1990 and is headquartered in Tampa, FL. | Health Technology |
Core Ventures II LLC
Core Ventures II LLC Investment ManagersFinance Core Ventures II LLC operates as a venture capital firm. The company is headquartered in Short Hills, NJ. | Finance |
SpineCore, Inc.
SpineCore, Inc. Industrial MachineryProducer Manufacturing SpineCore, Inc. was a privately-owned developer of artificial lumbar and cervical discs located at Summit, NJ. SpineCore was founded in 2001 by Thomas Errico, MD and J.P. Errico | Producer Manufacturing |
K2 Medical Systems Ltd.
K2 Medical Systems Ltd. Medical/Nursing ServicesHealth Services K2 Medical Systems Ltd. provides maternity care services. Its products include k2 athena, infant-guardian, hampton, PTP, and portal. The company was founded by Robert Duncan Falconer Keith, Joseph Errico and David Shine in July 1989 and is headquartered in Plymouth, the United Kingdom. | Health Services |
Fastenetix LLC | |
Ad4 Pharma |